Market Intelligence

Southern Water launches employer-paid health cash plan

Posted on by Greg Judd

Greg Judd’s Insight: Have you seen this article?  This is evidence that there is room for health benefits innovation around the globe – even where health coverage is “taken care  of”…. 6 October 2014 | By Robert Crawford  Originally posted: http://www.employeebenefits.co.uk/benefits/healthcare-and-wellbeing/southern-water-launches-employer-paid-health-cash-plan/105634.article EXCLUSIVE: Southern Water has launched an employer-funded health cash plan for its 2,000 employees. The scheme, ‘your Health Cash […]

Continue reading →
Trends

Trends: Big Brands Reducing Negative Impact

Posted on by John Santilli

Consumers are paying attention.  From Goodwill’s obnoxiously low pay for disabled workers to the latest smoke-and-mirrors shuffling from quantitative easing, consumers are watching brands and businesses far more closely than in recent years for unethical policies and practices. In response, businesses are becoming much more proactive in reducing negative impacts to their brand, because they […]

Continue reading →
Distribution

Genentech Distribution Decision

Posted on by John Santilli

This is an example of a pharmaceutical company helping another group of healthcare stakeholders, health plans, because of an issue with health systems increasing cost of care. Stakeholders in the healthcare market, while working to reduce the cost of care, are trying to determine the best path to profitability. An example is Genentech’s decision to […]

Continue reading →
Market Intelligence

Continuation in rising costs of specialty drugs and maybe accelerate in next 1-2 years

Posted on by Dr. Randy

Gilead Sciences’ ($GILD) hep C drug Sovaldi burst onto the market, impressing doctors and patients with its benefits and outraging payers and politicians with its price. It reached blockbuster status twice over in the course of a single quarter. But instead of an aberration, a new report suggests it is a reflection of a trend that has […]

Continue reading →
Education, Market Intelligence

Educational Classes Offered

Posted on by John Santilli

I mentioned that there would be some benefits for you from my partnership with Dr. Randy Vogenberg at Healthcare Business & Insurance Institute while I’m transitioning my clients to Access Market Intelligence, our new joint venture. Because of our partnership, I’m able to offer you a special opportunity for two new classes being offered by HBI. As […]

Continue reading →
Clinical Collaborations

Clinical trial collaborations – an idea whose time has come

Posted on by John Santilli

The cost and time commitment to develop new drugs has increased significantly over the last few decades. A variety of factors come into play, but on average, in terms of total expenditures, it has taken from $3 to $5 billion and up to 15 years to bring a new drug to market. Even after all […]

Continue reading →
Market Intelligence

Knowsource.com Announces Transition to Access Market Intelligence

Posted on by John Santilli

I’ve mentioned the rapid changes in the healthcare and pharmaceutical industries that are impacting our sector and how we conduct business within its landscape. Because of the changes I’ve seen coming, I asked for your feedback in a survey to determine what concerns you have with these changes and the best course of action to […]

Continue reading →